1. Home
  2. KLTOW vs FND Comparison

KLTOW vs FND Comparison

Compare KLTOW & FND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTOW
  • FND
  • Stock Information
  • Founded
  • KLTOW N/A
  • FND 2000
  • Country
  • KLTOW United States
  • FND United States
  • Employees
  • KLTOW 3
  • FND N/A
  • Industry
  • KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
  • FND RETAIL: Building Materials
  • Sector
  • KLTOW Health Care
  • FND Consumer Discretionary
  • Exchange
  • KLTOW Nasdaq
  • FND Nasdaq
  • Market Cap
  • KLTOW N/A
  • FND 7.4B
  • IPO Year
  • KLTOW 2022
  • FND 2017
  • Fundamental
  • Price
  • KLTOW $0.18
  • FND $70.79
  • Analyst Decision
  • KLTOW
  • FND Hold
  • Analyst Count
  • KLTOW 0
  • FND 16
  • Target Price
  • KLTOW N/A
  • FND $87.63
  • AVG Volume (30 Days)
  • KLTOW N/A
  • FND 2.2M
  • Earning Date
  • KLTOW N/A
  • FND 10-30-2025
  • Dividend Yield
  • KLTOW N/A
  • FND N/A
  • EPS Growth
  • KLTOW N/A
  • FND N/A
  • EPS
  • KLTOW N/A
  • FND 1.94
  • Revenue
  • KLTOW N/A
  • FND $4,600,232,000.00
  • Revenue This Year
  • KLTOW N/A
  • FND $6.47
  • Revenue Next Year
  • KLTOW N/A
  • FND $8.71
  • P/E Ratio
  • KLTOW N/A
  • FND $36.54
  • Revenue Growth
  • KLTOW N/A
  • FND 4.88
  • 52 Week Low
  • KLTOW N/A
  • FND $66.01
  • 52 Week High
  • KLTOW N/A
  • FND $122.90
  • Technical
  • Relative Strength Index (RSI)
  • KLTOW 52.21
  • FND 37.77
  • Support Level
  • KLTOW $0.15
  • FND $67.01
  • Resistance Level
  • KLTOW $0.19
  • FND $72.33
  • Average True Range (ATR)
  • KLTOW 0.04
  • FND 2.40
  • MACD
  • KLTOW 0.00
  • FND -0.10
  • Stochastic Oscillator
  • KLTOW 68.18
  • FND 38.99

About KLTOW Klotho Neurosciences Inc. Warrant

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About FND Floor & Decor Holdings Inc.

Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site.

Share on Social Networks: